Australia’s Alkane Resources Ltd (ASX:ALK) announced plans to acquire Canada’s Mandalay Resources Corp (TSX:MND) in an all-share transaction, creating a diversified mid-tier gold and antimony producer with assets in Australia and Sweden. Under the agreement, Alkane will issue 7.875 shares for each Mandalay share, resulting in Mandalay shareholders owning approximately 55% of the combined company.
The merged entity will have an estimated market capitalization of A$1.01 billion ($650 million) and operate three producing mines. Gold-equivalent production is projected at around 160,000 ounces in 2025, rising to over 180,000 ounces by 2026. Alkane’s Managing Director, Nic Earner, will lead the new group, which plans to maintain its ASX listing while pursuing a dual listing on the TSX to enhance trading liquidity and investor reach.
The companies expect the merger to improve valuation prospects and trading activity. Completion of the deal is anticipated in the third quarter of 2025, subject to shareholder and regulatory approvals. The move positions Alkane and Mandalay to strengthen their presence in the gold and antimony markets, with growth-focused operations across key mining jurisdictions.


Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Washington Post Publisher Will Lewis Steps Down After Layoffs
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



